Literature DB >> 12123803

A thermosensitive mutant of HRV2 2A proteinase: evidence for direct cleavage of eIF4GI and eIF4GII.

Hans Dieter Liebig1, Joachim Seipelt, Elena Vassilieva, Alessandra Gradi, Ernst Kuechler.   

Abstract

Infection of mammalian cells with picornaviruses like entero-, rhino-, and aphthoviruses leads to an inhibition of cap-dependent cellular protein synthesis by the cleavage of both translation initiation factors, eIF4GI and eIF4GII. In entero- and rhinovirus infection this cleavage process is mediated by the viral 2A proteinase (2A(pro)). In order to discriminate between a direct mode of eIF4G cleavage and an indirect cleavage via activation of a cellular proteinase, a thermosensitive 2A(pro) mutant (ts-2A(pro)) of human rhinovirus 2 was employed. Temperature shift experiments of cytoplasmic HeLa cell extracts incubated with ts-2A(pro) strongly support a direct mode of cleavage of eIF4GI and eIF4GII by the viral 2A(pro).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12123803     DOI: 10.1016/s0014-5793(02)02933-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Cleavage of host keratin 8 by a Chlamydia-secreted protease.

Authors:  Feng Dong; Heng Su; Yanqing Huang; Youmin Zhong; Guangming Zhong
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

2.  Disruption of MDA5-Mediated Innate Immune Responses by the 3C Proteins of Coxsackievirus A16, Coxsackievirus A6, and Enterovirus D68.

Authors:  Yajuan Rui; Jiaming Su; Hong Wang; Junliang Chang; Shaohua Wang; Wenwen Zheng; Yong Cai; Wei Wei; James T Gordy; Richard Markham; Wei Kong; Wenyan Zhang; Xiao-Fang Yu
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

3.  Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1.

Authors:  Jing Lu; Lina Yi; Jin Zhao; Jun Yu; Ying Chen; Marie C Lin; Hsiang-Fu Kung; Ming-Liang He
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

4.  Cumulative mutations in the genome of Echovirus 6 during establishment of a chronic infection in precursors of glial cells.

Authors:  Frederik Beaulieux; Youssef Zreik; Christelle Deleage; Valerie Sauvinet; Vincent Legay; Pascale Giraudon; Katherine M Kean; Bruno Lina
Journal:  Virus Genes       Date:  2005-01       Impact factor: 2.332

5.  Proteinase 2Apro is essential for enterovirus replication in type I interferon-treated cells.

Authors:  Juliet M Morrison; Vincent R Racaniello
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

6.  The linker domain of poly(rC) binding protein 2 is a major determinant in poliovirus cap-independent translation.

Authors:  Polen Sean; Joseph H C Nguyen; Bert L Semler
Journal:  Virology       Date:  2008-07-25       Impact factor: 3.616

7.  Structural view of the 2A protease from human rhinovirus C15.

Authors:  Hui Ling; Pan Yang; Hai Hou; Yao Sun
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2018-03-28       Impact factor: 1.056

Review 8.  The Nuclear Pore Complex Is a Key Target of Viral Proteases to Promote Viral Replication.

Authors:  Luis Adrián De Jesús-González; Selvin Palacios-Rápalo; José Manuel Reyes-Ruiz; Juan Fidel Osuna-Ramos; Carlos Daniel Cordero-Rivera; Carlos Noé Farfan-Morales; Ana Lorena Gutiérrez-Escolano; Rosa María Del Ángel
Journal:  Viruses       Date:  2021-04-19       Impact factor: 5.048

Review 9.  Respiratory virus modulation of host nucleocytoplasmic transport; target for therapeutic intervention?

Authors:  Leon Caly; Reena Ghildyal; David A Jans
Journal:  Front Microbiol       Date:  2015-08-14       Impact factor: 5.640

10.  Solution structure of the 2A protease from a common cold agent, human rhinovirus C2, strain W12.

Authors:  Woonghee Lee; Kelly E Watters; Andrew T Troupis; Nichole M Reinen; Fabian P Suchy; Kylie L Moyer; Ronnie O Frederick; Marco Tonelli; David J Aceti; Ann C Palmenberg; John L Markley
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.